138 related articles for article (PubMed ID: 10203244)
1. Adaptive changes of serotonin 5-HT2A receptors in mice lacking the serotonin transporter.
Rioux A; Fabre V; Lesch KP; Moessner R; Murphy DL; Lanfumey L; Hamon M; Martres MP
Neurosci Lett; 1999 Mar; 262(2):113-6. PubMed ID: 10203244
[TBL] [Abstract][Full Text] [Related]
2. Brain region-specific alterations of 5-HT2A and 5-HT2C receptors in serotonin transporter knockout mice.
Li Q; Wichems CH; Ma L; Van de Kar LD; Garcia F; Murphy DL
J Neurochem; 2003 Mar; 84(6):1256-65. PubMed ID: 12614326
[TBL] [Abstract][Full Text] [Related]
3. Reduction in the density and expression, but not G-protein coupling, of serotonin receptors (5-HT1A) in 5-HT transporter knock-out mice: gender and brain region differences.
Li Q; Wichems C; Heils A; Lesch KP; Murphy DL
J Neurosci; 2000 Nov; 20(21):7888-95. PubMed ID: 11050108
[TBL] [Abstract][Full Text] [Related]
4. Neurotransmitter action in osteoblasts: expression of a functional system for serotonin receptor activation and reuptake.
Bliziotes MM; Eshleman AJ; Zhang XW; Wiren KM
Bone; 2001 Nov; 29(5):477-86. PubMed ID: 11704501
[TBL] [Abstract][Full Text] [Related]
5. Mechanical, thermal and formalin-induced nociception is differentially altered in 5-HT1A-/-, 5-HT1B-/-, 5-HT2A-/-, 5-HT3A-/- and 5-HTT-/- knock-out male mice.
Kayser V; Elfassi IE; Aubel B; Melfort M; Julius D; Gingrich JA; Hamon M; Bourgoin S
Pain; 2007 Aug; 130(3):235-248. PubMed ID: 17250964
[TBL] [Abstract][Full Text] [Related]
6. [Effect of hypothyroidism on 5-HT1A-, 5-HT2A-receptors and serotonin transporter in the rat brain].
Kulikov AV; Jeanningro R
Ross Fiziol Zh Im I M Sechenova; 2000 Mar; 86(3):312-9. PubMed ID: 10808528
[TBL] [Abstract][Full Text] [Related]
7. [Implication of serotonin in the control of vigilance states as revealed by knockout-mouse studies].
Adrien J
J Soc Biol; 2004; 198(1):30-6. PubMed ID: 15146953
[TBL] [Abstract][Full Text] [Related]
8. Evidence that genetic variation in 5-HT transporter expression is linked to changes in 5-HT2A receptor function.
Jennings KA; Sheward WJ; Harmar AJ; Sharp T
Neuropharmacology; 2008 Apr; 54(5):776-83. PubMed ID: 18241894
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of LY393558, an inhibitor of the 5-hydroxytryptamine transporter with 5-HT(1B/1D/2) receptor antagonist properties.
Pullar IA; Boot JR; Carney SL; Cohen ML; Colvin EM; Conway RG; Hardy CH; Lucaites VL; Nelson DL; Schenck KW; Tomlinson R; Wedley S
Eur J Pharmacol; 2001 Nov; 432(1):9-17. PubMed ID: 11734182
[TBL] [Abstract][Full Text] [Related]
10. Agonist and antagonist binding to rabbit cortical 5-HT2A receptors: opposite effects of magnesium.
Aloyo VJ; Salt GL; Hoffman ME; Harvey JA
Ann N Y Acad Sci; 1998 Dec; 861():280. PubMed ID: 9928290
[No Abstract] [Full Text] [Related]
11. Antagonist binding at 5-HT(2A) and 5-HT(2C) receptors in the rabbit: high correlation with the profile for the human receptors.
Aloyo VJ; Harvey JA
Eur J Pharmacol; 2000 Oct; 406(2):163-9. PubMed ID: 11020478
[TBL] [Abstract][Full Text] [Related]
12. [3H]MDL 100,907 labels 5-HT2A serotonin receptors selectively in primate brain.
López-Giménez JF; Vilaró MT; Palacios JM; Mengod G
Neuropharmacology; 1998 Sep; 37(9):1147-58. PubMed ID: 9833645
[TBL] [Abstract][Full Text] [Related]
13. Reduced programmed cell death in brains of serotonin transporter knockout mice.
Persico AM; Baldi A; Dell'Acqua ML; Moessner R; Murphy DL; Lesch KP; Keller F
Neuroreport; 2003 Mar; 14(3):341-4. PubMed ID: 12634480
[TBL] [Abstract][Full Text] [Related]
14. Reduction of 5-hydroxytryptamine (5-HT)(1A)-mediated temperature and neuroendocrine responses and 5-HT(1A) binding sites in 5-HT transporter knockout mice.
Li Q; Wichems C; Heils A; Van De Kar LD; Lesch KP; Murphy DL
J Pharmacol Exp Ther; 1999 Dec; 291(3):999-1007. PubMed ID: 10565817
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of [m-methoxy 3H]MDL100907 binding to 5HT2A receptors in cerebral cortex and brain stem of streptozotocin induced diabetic rats.
Jackson J; Paulose CS
Mol Cell Biochem; 1999 Sep; 199(1-2):81-5. PubMed ID: 10544955
[TBL] [Abstract][Full Text] [Related]
16. Mapping of 5-HT2A receptors and their mRNA in monkey brain: [3H]MDL100,907 autoradiography and in situ hybridization studies.
López-Giménez JF; Vilaró MT; Palacios JM; Mengod G
J Comp Neurol; 2001 Jan; 429(4):571-89. PubMed ID: 11135236
[TBL] [Abstract][Full Text] [Related]
17. Molecular serotonergic mechanisms appear to mediate genetic sensitivity to cocaine-induced convulsions.
O'Dell LE; Li R; George FR; Ritz MC
Brain Res; 2000 Apr; 863(1-2):213-24. PubMed ID: 10773209
[TBL] [Abstract][Full Text] [Related]
18. Platelet 5-hydroxytryptamine (5-HT) transporter and 5-HT2A receptor binding after chronic hypercorticosteronemia, (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane administration or neurotoxin-induced depletion of central nervous system 5-HT in the rat.
Owens MJ; Ballenger CA; Knight DL; Nemeroff CB
J Pharmacol Exp Ther; 1996 Sep; 278(3):1040-9. PubMed ID: 8819484
[TBL] [Abstract][Full Text] [Related]
19. Exaggerated effect of fluvoxamine in heterozygote serotonin transporter knockout mice.
Montañez S; Owens WA; Gould GG; Murphy DL; Daws LC
J Neurochem; 2003 Jul; 86(1):210-9. PubMed ID: 12807440
[TBL] [Abstract][Full Text] [Related]
20. LY367265, an inhibitor of the 5-hydroxytryptamine transporter and 5-hydroxytryptamine(2A) receptor antagonist: a comparison with the antidepressant, nefazodone.
Pullar IA; Carney SL; Colvin EM; Lucaites VL; Nelson DL; Wedley S
Eur J Pharmacol; 2000 Oct; 407(1-2):39-46. PubMed ID: 11050288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
